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Background: Bipolar disorder (BD) and temporal lobe epilepsy (TLE) overlap in domains 
including epidemiology, treatment response, shared neurotransmitter involvement and 
temporal lobe pathology. Comparison of cognitive function in both disorders may indi-
cate temporal lobe mediated processes relevant to BD. This systematic review examines 
neuropsychological test profiles in euthymic bipolar disorder type I (BD-I) and pre-surgical 
TLE and compares experimental designs used.
Methods: A search of PubMed, PsychINFO, and Scopus using Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses guidelines was conducted. Inclusion 
criteria were comparison group or pre- to post-surgical patients; reported neuropsy-
chological tests; participants aged 18–60 years. Fifty six studies met criteria: 27 BD-I; 
29 TLE.
Results: Deficits in BD-I compared to healthy controls (HC) were in executive function, 
attention span and verbal memory. Deficits in TLE compared to HC were in executive 
function and memory. In the pre- to post-surgical comparisons, verbal memory in left 
temporal lobe (LTL) and, less consistently, visuospatial memory in right temporal lobe 
(RTL) epilepsy declined following surgery. BD-I studies used comprehensive test batteries 
in well-defined euthymic patients compared to matched HC groups. TLE studies used 
convenience samples pre- to post-surgery, comparing LTL and RTL subgroups, few 
included comparisons to HC (5 studies). TLE studies typically examined a narrow range 
of known temporal lobe-mediated neuropsychological functions, particularly verbal and 
visuospatial memory.
Conclusion: Both disorders exhibit deficits in executive function and verbal memory 
suggestive of both frontal and temporal lobe involvement. However, deficits in TLE 
are measured pre- to post-surgery and not controlled at baseline pre-surgery. Further 
research involving a head-to-head comparison of the two disorders on a broad range of 
neuropsychological tests is needed to clarify the nature and extent of cognitive deficits 
and potential overlaps.
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iNTRODUCTiON
Bipolar disorder type I (BD-I) is typically characterized by epi-
sodes of mania and depression with inter-episode euthymia. A 
number of impairments have been noted in the euthymic phase 
of the illness including social, occupational functioning, and 
cognitive deficits (1, 2).
Most studies have examined cognitive deficits in euthymic 
patients with BD-I compared to healthy controls (HC). Five 
meta-analyses have reported impairments in cognitive domains 
of executive functioning (3–7), verbal memory (3, 5–7), visuos-
patial memory (7), and attention (4, 6). One meta-analysis found 
no impairment of verbal memory and executive function in BD-I 
compared to HC (8). An individual patient data meta-analysis by 
Bourne et al. (9) reported impaired verbal memory and attention 
in euthymic BD-I patients relative to HC (9). The absence of an 
association between cognitive impairment and medication dose 
in euthymic BD-I patients suggest the effects of medication do 
not fully account for the cognitive impairments observed (4). 
These meta-analyses support the assumption that cognitive 
impairments exhibited in the euthymic phase are trait markers 
of the disorder.
An alternate research design is to compare and contrast 
cognitive deficits in BD-I to a reference condition which shares 
common features. For example, a meta-analysis comparing BD-I 
and schizophrenia reported more pronounced cognitive deficits 
in schizophrenia on measures of verbal fluency, verbal memory, 
executive function, visuospatial memory, mental speed, IQ, and 
concept formation (10). Similarly a single study comparing BD-I, 
obsessive compulsive disorder reported impaired verbal and 
episodic memory compared to HC (11). The BD-I group had 
greater impairments in learning word lists and delayed recall. 
These results suggest the importance of the temporal lobes in 
both disorders in the consolidation and retrieval of memories.
A single study compared BD-I with complex partial seizure 
disorder (12). It is noted that the classification of epilepsy syn-
dromes has been subject to a number of iterations. In this review, 
we use the most commonly reported and widely understood term 
“temporal lobe epilepsy (TLE)” to incorporate the terms complex 
partial seizure disorder and focal seizures arising from the tem-
poral lobes. The Jones et al. study reported greater impairment 
of executive function, attention and delayed verbal recall in the 
TLE group. These results should be interpreted with caution given 
the small and unequal sample sizes (BD-I n = 26, TLE n = 9). 
A case can be made for further exploration of similarities and 
differences between the neuropsychological test profiles seen in 
euthymic BD-I and interictal TLE. This is particularly so given 
the localizing pathology of TLE, which allows inferences to be 
made regarding the contribution of temporal lobe processes to 
the range of cognitive deficits reported in BD-I.
There are a number of established similarities between BD-I 
and TLE. These typically include a chronic course punctuated by 
episodic manifestations of mania and seizures, respectively. Other 
similarities include: the proposed involvement of kindling mecha-
nisms (13); changes in neurotransmitters (excitatory amino acids, 
GABA, dopamine and serotonin), voltage-opened ion channels 
(sodium, calcium and potassium) and second messenger systems 
(G-proteins, phosphatidylinositol, protein kinase C, myristoylated 
alanine-rich C kinase substrate), and treatment response to antie-
pileptic medications in both disorders (14).
In addition, episodes in both disorders commonly feature 
sensory, perceptual, cognitive, and affective changes (15) includ-
ing depression (16). Epidemiological studies have shown that 
the proportion of BD-I among people with epilepsy is more than 
twice as high as in the general population (17) and that mania is 
more common in patients with TLE than in the general popula-
tion (18). BD-I is also associated with comorbid epilepsy but not 
parental epilepsy (19). Episodes of mania in BD-I and seizures in 
TLE share precipitating factors including stress, sleep reduction 
and antidepressant medications (20).
The temporal lobes have also been the subject of neuroimaging 
research in both disorders. In BD-I many studies have investigated 
correlates of the disorder to specific brain regions. Meta-analyses 
of magnetic resonance imaging (MRI) studies have reported that 
BD-I is associated with right lateral ventricular enlargement (21) 
and an enlarged left amygdala (22). However, studies of temporal 
lobe size are inconsistent; with reported increases (23), reductions 
(24) or no differences (25–28) likely reflecting the difficulties of 
defining and measuring the volume of individual cerebral lobes 
on MRI.
In TLE, MRI studies have reported structural brain abnormali-
ties in the hippocampus, entorhinal cortex (29), thalamus (30), 
and fornix (31). On voxel-based morphometry, TLE is associated 
with gray matter pathology in the hippocampus, cingulum, thala-
mus, and frontal lobes. White matter reductions ipsilateral to the 
seizure focus were also found in the temporopolar, entorhinal, 
and perirhinal areas (32). Typically, TLE originates unilaterally 
from the medial temporal lobe; they may, however, be propagated 
from other regions which project to limbic areas (33).
Given these potential diffuse structural abnormalities seen in 
patients with TLE, it could be expected that neuropsychologi-
cal deficits may not be limited to tasks involving temporal lobe 
function. Patients with TLE display deficits in memory, general 
intelligence, language, executive function, and motor speed 
relative to HC (34, 35). Deficits in verbal memory, language, 
and psychomotor speed may be affected by factors such as age 
of onset of epilepsy, general intelligence, the number and dose of 
antiepileptic medications used, and seizure frequency (35).
The literature describing clinical features, imaging findings, 
and neuropsychological test profiles is largely in a separate corpus 
for BD-I and for TLE with only one small study directly compar-
ing the two (12).
The current structured review brings these two bodies of 
work together in a comparison of the neurocognition literature 
findings of the two conditions side-by-side. The aim is to deter-
mine whether and to what extent the cognitive impairments 
seen in euthymic BD-I are mirrored by those attributed to a 
pathology primarily affecting the temporal lobes, that is TLE.
MeTHOD
This systematic review was conducted in accordance with the 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (36).
FigURe 1 | Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses flow diagram of included studies.
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Inclusion criteria: (a) controlled comparison, (b) patients 
diagnosed with BD-I as assessed by a recognized criterion-based 
diagnostic system, (c) BD-I patients rated as euthymic, defined 
by their scores on a rating scale (<8 HamD, <8 YMRS); patients 
with unilateral TLE, from any cause, with diagnosis confirmed in 
a pre-surgical workup, (d) at least one neuropsychological test, 
(e) adult participants (18–60 years), (f) in the case of more than 
one article by the same authors results were not identified as being 
from the same sample, (f) articles published 1980 or later.
identification of Studies
A comprehensive search of the electronic databases PubMed, 
PsychINFO, and Scopus for peer-reviewed articles published 
in English was conducted in the last week of May 2016. Search 
terms were grouped as follows: bipolar, manic depress*, baseline, 
asympt*, remit*, stable (group 1); or epilep*, seizure, presurg*, 
temporal, focal, partial, complex, interictal (group 2) and WAIS, 
Wechsler, trail making, continuous performance, stroop, digit 
span, verbal learning, rey, working memory, benton, card sort*, 
verbal fluency, RAVLT, CAVLT, tower of London (group 3). These 
search terms were combined as follows: group 1 AND group 3 for 
BD-I and group 2 AND group 3 for TLE.
Data extraction
The abstracts located from the search strategy were entered into 
EndNoteX7. The PRISMA flowchart (Figure 1) sets out the steps 
in screening conducted by author EB. After the screening of titles 
and abstracts the remaining 139 studies were examined in full 
text, using a purpose built coding sheet to assess whether they 
met inclusion criteria. This process resulted in the study sample 
of 56, of which 27 related to BD-I and 29 to TLE.
ReSULTS
The search strategy identified an initial 3,307 articles of which 56 
met inclusion criteria, 27 related to BD-I and 29 to pre-surgical 
TLE. Studies of BD-I are summarized in Table 1 and of TLE in 
Table 2 detailing authors, sample sizes, medication (BD-I only as 
this was not recorded in the TLE samples), neuropsychological 
test parameters, and summary results.
As demonstrated in Table  1, 25 of 27 studies compared 
patients with BD-I (n = 1,398) to HC (n = 1,142). The remaining 
studies compared manic, euthymic, and depressed groups. The 
most commonly reported impairments in BD-I were in executive 
function, attention span, and verbal memory. No studies found 
enhanced neuropsychological function in euthymic BD-I.
As shown in Table 2, in the epilepsy literature, all of the TLE 
studies compared neuropsychological test performance pre- to 
post-surgery. Only 5 of the 29 studies compared pre-surgical 
TLE (n = 150) to HC (n = 111); these studies found significant 
impairments in TLE compared to HC on tests of memory and 
executive function.
In 26 of the TLE studies, the samples were divided by laterality 
of seizure focus with the primary pathology affecting the right 
temporal lobe (RTL n =  846) or the left temporal lobe (LTL 
n =  1,068). In pre-surgical TLE, the direct comparison of LTL 
and RTL groups indicated that the LTL group showed impaired 
verbal memory and the RTL group, less consistently, impaired 
visuospatial memory.
The most common impairment observed in TLE related to 
surgery was in verbal memory. This finding was also associated 
with laterality, 24 studies reporting decline in verbal memory 
from pre- to post-surgery in LTL patients, whereas in RTL there 
was a less consistent decline in visuospatial memory. No signifi-
cant differences in attention were found for laterality or pre- to 
post-surgery in TLE.
Table  3 shows the results of individual neuropsychological 
tests that were reported in more than one study, for BD-I and 
TLE. Of note, the total number of neuropsychological tests used 
across all studies differed between BD-I (27) and TLE (11); this 
was not evenly distributed across cognitive domains. The number 
of studies where any executive function instrument was admin-
istered in TLE was only 4 (2 WCST, 2 COWAT) of 29 compared 
to 21 of 27 in BD-I. One study compared RTL, LTL and HC and 
showed that all patients were impaired on the WCST relative 
to HC (87). The number of studies where any verbal memory 
instrument was administered was 26 of 29 in TLE compared to 
14 of 27 in BD-I. The comparable figures for visuospatial memory 
instruments were 25 of 29 in TLE and 11 of 27 in BD-I. Similarly, 
only 6 studies measured attention in TLE compared to 17 studies 
in BD-I. Thus, while both fields have seen sustained research 
activity in identifying neuropsychological deficits, the focus of 
inquiry in TLE has been on verbal and visuospatial memory and 
in BD-I executive function.
Notwithstanding the differences in the intensity and focus of 
neuropsychological testing in both conditions, consistent results 
emerging from this study emphasize deficits in verbal memory, 
which have been reported in the majority of studies that have 
examined this area in both BD-I and TLE.
TaBLe 1 | Summary of included studies on euthymic bipolar disorder.
Reference n Medications bipolar 
sample
Neuropsychological test parameters Results
Altshuler et al. (37) BD 40 Li 25, AC 12, AD 4, AP 
6, BZD 3
WAIS-R block design, vocab; TMT, WCST, 
Stroop; VFT, CVLT; ROCFT; Star mirror 
tracing Task, PR
BD impaired verbal memory and executive 
functioningSZ 20
HC 22
Bas et al. (38) BD 60 Li 39, AP 37, LTG 9, 
VPA 21
Stroop, TMT A and B; WMS-R visual 
reproduction; RAVLT
BD impaired on RAVLT
HC 41
Bora et al. (39) BD 514 Li 63.2%, VPA 47.6%, 
AP 47.2%, AD 5.7%
Stroop. WCST Deficits exist in subgroups who have severe and 
global cognitive deficitsBD-II 42
HC 416
Chang et al. (40) BD 23 BD Li 13, AP 15, LTG 
7, VPA 9
WAIS-R block design and vocab; CVLT, 
VFT
All NS
BD-II 23
HC 23
Chou et al. (41) BD 23 AP 13, VPA 19 The Color Trails Test, WCST; WMS-III – 
Word Lists Test, Face Test; Go/No-GO, 
Test for Attentional Performance
BD impaired faces memory and WCST
HC 33
Deckersbach et al. (42) BD 25 Li 11, AC 9, AD 9, AP 3 ROCFT Immediate recall BD impaired, copy and recognition 
preservedHC 25
Deckersbach et al. (11) BD 30 Li 13, AC 11, AD 8, 
AP 4
CVLT CVLT BD impaired learning and delayed free recall
Obsessive 
compulsive 
disorder 30
HC 30
Dell’Osso et al. (43) BD 15 BD Mono 2, Poly 12 N-Back NS HC and BD
BD-II13
HC 27
Dittmann et al. (44) BD 65 BD Li 27, AD 10, AP 
33, CBZ 4, VPA 28
TMT; HAWIE-R; WAIS-III letter number 
sequencing; RBANS
Psychomotor speed, working and delayed memory, 
verbal learning, executive functioning BD impairedBD-II 38
HC 62
Dixon et al. (45) BD manic 15 dep 
15, eu 15, HC 30
Eu Li 15, AD 8, AP 10, 
AC 2
WAIS-R Vocab; Stroop; FAS; Hayling 
sentence completion test; Cognitive 
Estimates Test
VF total responses, Hayling response initiation 
latency, error score and using strategy, stroop EuBD 
impaired
Doganavs¸argil-Baysal 
et al. (46)
BD 60 Li 11, MS + AP 12, 
2MS 12, VPA 6
WCST, TMT, Stroop; RAVLT; Cancelation 
test
Significant differences on all measures between BD 
and HCHC 20
Doganavs¸argil-Baysal 
et al. (46)
BD 54 Li 10, MS + AP 27, 
2MS 11, VPA 5
WCST; RAVLT Both measures BD < HC
HC 18
Doruk et al. (47) Manic 20 Unknown Stroop; Serial Digit Learning Test; RAVLT; 
Cancelation Test
NS HC and EuBD
Dep10
Eu 21
Fistikci et al. (48) BD 25 Li 25 WCST; Montreal Cognitive Assessment NS HC and BD
HC 25
Frangou et al. (49) BD 10 Li 5, AC 3 WCST; Hayling sentence completion WCST BD and offspring made more errors
Un offspring 15
HC 43
Hsiao et al. (50) BD 30 VPA 29 WAIS-III digit symbol; TMT; WMS-III Verbal memory, working memory, psychomotor 
speed, executive function BD impairedBD-II 37
HC 22
Martino et al. (51) BD 48 AD 16, AP 28, BZD 23, 
MS 48
WAIS vocab, digit span; TMT, WCST, IGT; 
Memory battery of Signoret
Verbal memory, attention and executive functions 
impairedBD-II 37
HC 34
Muralidharan et al. (52) BD 72 AP 27, Li 34, VPA 38 TMT, Stroop; CANTAB; CVLT; WMS-III 
LNS
P on VPA more working memory deficits than Li 
or HCHC 40
Muralidharan et al. (53) BD 68 AP 51, Li 32, MS + AP 
50, VPA 32
TMT, Stroop; CANTAB; CVLT; WMS-III 
letter number sequencing 
Verbal and visuospatial memory, working memory 
and executive function BD impaired.HC 38
Normala et al. (54) BD 40 AP 6, MS 11, MS + AD 
1, MS + AP22
WAIS Digit span; TMT; Verbal Fluency Executive and attention functioning BD impaired
HC 40
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(Continued)
Reference n Medications bipolar 
sample
Neuropsychological test parameters Results
Pattanayak et al. (55) BD 30 AP 5, LTG 2, Li 21, 
VPA 11
VIQ; TMT, Stroop; N-Back; Postgraduate 
Institute Memory Scale
Attention, information processing speed, executive 
function, verbal memory BD impairedHC 20
Radwan (56) BD 30 Unknown WAIS; WCST; WMS; CPT All BD impaired
HC 30
Sepede et al. (57) BD 24 AD 10, AP 15, BZD 8, 
Li 3, MS 9
CPT Sustained attention impaired BD and rels
Unaffected rels 
33
HC 24
Trivedi et al. (58) BD 15 CBZ 1, Li 8, VPA 6 WCST; SWMT; CPT Executive function BD impaired
HC 15
Trivedi et al. (59) BD 15 Unknown WCST; SWMT; CPT Executive function BD impaired
SZ 15, HC 15
Yates et al. (60) BD dep 34 AD 9, AP 18, BZD 9, 
MS 29
WAIS-III Verbal measure BD impaired
BDEu 31, HC 34
Zubieta et al. (61) BD 15 AP 3, CBZ 2, Li 7, 
VPA 12
WAIS-R: digit span; WCST, Stroop; 
WMS-R; verbal fluency; test of variable 
attention
Verbal learning, executive function, motor 
coordination and sequential memory BD impaired. 
NS verbal fluency or attention
HC 15
BD, bipolar; BD-II, bipolar II; HC, healthy controls; SZ, Schizophrenia; Li, lithium; AC, anticonvulsant; AD, antidepressant; AP, antipsychotics; BZD, benzodiazepine; CBZ, 
carbamazepine; LTG, lamotrigine; MS, mood stabilizer; VPA, valproate; Mono, monotherapy; Poly, polytherapy; AMIPB, Adult Memory and Information Processing Battery; BVRT, 
Benton Visual Retention Test; VLMT, Verbaler Lern- und Merkfähigkeitstest; DCS-R, Diagnosticum für Cerebralschädigung – II; NAART, North American Adult Reading Test; WRAT, 
Wide Range Achievement Test; WAIS, Wechsler Adult Intelligence Scale; CPT, Continuous Performance Test; CVLT, California Verbal Learning Test; RAVLT, Rey Auditory Verbal 
Learning Test; WCST, Wisconsin Card Sorting Test.
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DiSCUSSiON
To our knowledge, this is the first systematic review directly 
comparing the literature on cognitive function in BD-I and TLE. 
Consistent with the meta-analyses of cognition in euthymic BD-I, 
our review showed impairments on a wide range of cognitive 
measures. In the individual studies reviewed, the most com-
monly reported impairments in BD-I were in executive function, 
attention span, and verbal memory. The impairments of executive 
function in patients with BD-I may be suggestive of an underlying 
dysfunction in the prefrontal cortex (3).
In TLE studies, a decline in pre- to post-surgery in verbal 
memory was commonly reported in patients with seizures 
originating from the LTL, and less consistently, in visuospatial 
memory in patients with RTL epilepsy. Functional MRI studies 
have revealed that the right hemisphere is associated with spatial 
memory (91). In our sample, executive function was not widely 
examined in patients with epilepsy; however, an impairment was 
found. For executive function, two instruments were employed 
across four studies, three of which showed a difference between 
pre- to post-surgery scores and one study found impaired perfor-
mance in TLE relative to HC participants.
In keeping with our results, meta-analyses of memory func-
tion pre- to post-surgery reported that, following a resection 
of the LTL, a clear decline in verbal memory is observed, an effect 
that is particularly salient for immediate verbal recall. However, 
the pattern of impairment following partial resection of the RTL 
showed a trend for improvement on tasks of non-verbal memory 
(92). This suggests that memory impairments are state markers 
affected by seizures and abnormalities in the temporal lobes. 
Other factors that affect cognitive performance in TLE are the 
chronicity of the condition, older age, lower intellect, and greater 
abnormalities shown on imaging (92). Another meta-analysis 
found that the evidence regarding post-surgery outcome on visu-
ospatial memory following right anterior temporal lobectomy 
was less clear (93).
In TLE, it is unclear whether frontal lobe impairments shown 
on executive function measures are a product of temporal lobe 
involvement or are a side effect of the propagation of epileptic 
activity from the epileptic zone (94). Other evidence has suggested 
that the prefrontal cortex, in particular the orbitofrontal cortex, 
is influenced by ictal discharges from the mesial temporal lobe 
(95). Some studies have shown that the temporal neocortex is 
implicated in executive function implying that a frontotemporal 
network is used for processing information (96).
This review emphasizes that prior research on cognitive 
impairments in the fields of BD-I and TLE has employed method-
ologies that reflect different research questions. The BD-I litera-
ture predominantly examines cognition as a characteristic of the 
disorder itself, on a par with symptoms and potentially amenable 
to therapeutic intervention. The TLE literature is concerned with 
the effects of ablative surgery that aims to remove seizure foci 
but may consequently also directly affect healthy brain tracts. 
It addresses whether cognitive function improves or declines 
subsequent to surgery and the moderating effects of laterality.
The majority of BD-I studies compare euthymic patients with 
HC, whereas in the epilepsy studies, patients act as their own con-
trols in relation to surgical intervention and laterality. In addition, 
given that the BD-I studies are interested in trait markers in the 
euthymic phase, they routinely report the quantitative differences 
between patients and HC, rendering the results suitable for incor-
poration in meta-analytic studies. The TLE literature has focused 
TaBLe 1 | Continued
TaBLe 2 | Summary of included studies on pre-surgical temporal lobe epilepsy (TLE).
Reference n Neuropsychological test parameters Results
Baxendale and Thompson (62) Right temporal lobe 
(RTL) 133
WAIS PIQ, VIQ; AMIPB Verbal memory decline post-surg left temporal lobe 
(LTL)
LTL 157
Baxendale et al. (63) RTL 146
LTL 177
WAIS PIQ, VIQ; AMIPB; Birt Memory and Information 
Processing Battery
RTL and LTL at equal risk of post-surg decline
Berenbaum et al. (64) LTL 57 WAIS Digit Span; CVLT CVLT decline post-surg
Bjørnaes et al. (65) RTL 50 WAIS Digit Span; Benton Visual Retention Test (BVRT); 
Design Learning and Retention Test; Verbal List 
Learning and Retention; Tactual Performance Test
Improvement at 2-year follow up post-surg
LTL 41
Chelune et al. (66) RTL 19 WAIS-R VIQ, PIQ; WMS-R, RAVLT; COWAT, Halstead-
Wepman Aphasia Screening Exam, BNT, Speech 
Sounds Perception Test; Hooper Visual Organization 
Test, Seashore Rhythm Test
LTL decline post-surg
LTL 23
Chiaravalloti et al. (67) RTL 16 WMS-III Faces Subtest; Graduate Hospital Facial 
Memory Test
RTL < LTL both pre- and post-surg
LTL 10
Chiaravalloti (68) RTL 42 CVLT; Graduate Hospital Facial Memory Test Verbal memory post-surg decline LTL, RTL improved. 
Visuospatial memory post-surg decline RTL, LTL 
improvement
LTL 28
Fernandes et al. (69) RTL 23 WAIS-R Block design, Vocabulary; WMS-R; RAVLT Cognitive scores post-surg decline low pre-surg 
scores. Non-verbal memory post-surg RTL decline, 
verbal and visuospatial memory LTL decline
LTL 24
healthy controls 
(HC) 28
Giovagnoli et al. (70) RTL 12 Raven’s Colored Progressive Matrices; Attentive 
Matrices; Verbal Selective Reminding Procedure, Story 
Recall, Verbal Memory Distractor Test; Visual Selective 
Reminding Procedure, ROCFT, Visual Memory 
Distractor Test
Verbal memory pre- and post-surgery LTL impaired 
relative to HC. Visual deficits present in both groups 
relative to HC
LTL 12
HC 36
Gleissner et al. (71) RTL 63 VLMT; DCR-S Verbal memory LTL decline
LTL 52
Glosser et al. (72) RTL 13 Boston Naming Test; CVLT Benton Facial Recognition, 
Graduate Hospital Facial Memory
Recognition of familiar faces and learning new faces 
RTL impaired. Names of familiar faces LTL impairedLTL 8
HC 10
Helmstaedter et al. (73) LTL 47 Verbal Learning and Memory Test; RAVLT Delayed recall and recognition post-surg improvement
Hermann and Wyler (74) RTL 14 COWAT; Token Test Language tests pre-surg LTL deficit
LTL 15
Hermann et al. (75) RTL 31 CVLT Verbal memory post-surg RTL increased
LTL 26
Hermann et al. (76) RTL 26 WAIS-R Digit Span; Multilingual Aphasia Examination 
Visual Naming Test; CVLT
CVLT post-surg decline LTL
LTL 36
Köylü et al. (77) RTL 12 List learning task LTL post-surg decline
LTL 14
Lee et al. (78) LTL 38 RAVLT; ROCFT Memory post-surg decline
Loring et al. (79) RTL 13 Selective Reminding Test, Serial Digit Learning, ROCFT, 
Form Sequence Learning
Complex figure RTL impaired. Verbal memory decline 
LTLLTL 16
Malikova et al. (80) RTL 11 WAIS-R; WMS-R; Verbal Fluency Test FSIQ, global and verbal memory, attention, and 
working memory all improved post-surgLTL 26
Morino et al. (81) RTL 31 WMS-R; Miyake Verbal Retention Test; BVRT Memory RTL improved post-surg. Verbal memory LTL 
post-surg improvedLTL 31
Quigg et al. (82) RTL 16 TMT; BNT; CVLT; WMS-R Logical Memory Scale BNT and CVLT LTL decreased post-surgery. 
Language and verbal memory LTL increased. TMT 
increased
LTL 14
Seidenberg et al. (83) RTL 30 CVLT Free recall LTL decline post-surgery
LTL 46
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(Continued)
Reference n Neuropsychological test parameters Results
Selwa et al. (84) RTL 14 WAIS-R; WMS FSIQ, Logical Memory RTL improved post-surg. 
Verbal memory decline LTL post-surgLTL 17
Non-surgical TLE 28
Shamim et al. (85) RTL 14 WAIS-III; WMS-III Verbal memory deficit post-surg LTL
LTL 16
Stretton et al. (86) RTL 17 WAIS-III Digit Span; Gesture Span Task; Motor 
Sequences Task; Dot-Back Paradigm
Working memory pre-surg RTL and LTL worse than 
HC. WM improved post-surg LTLLTL 16
HC 15
Tisser et al. (87) RTL 10 WAIS-R; WCST WCST RTL and LTL impaired, improved post-surg
LTL 15
HC 22
Trenerry and Jack (88) RTL 34 WAIS-R; WCST The WCST is not useful for lateralizing seizure onset 
in TLELTL 34
Trenerry et al. (89) RTL 36 WAIS-R; WMS-R; RAVLT; Visual Spatial Learning Test Verbal and visual memory LTL improved post-surg
LTL 44
von Rhein et al. (90) RTL 20 VLMT; DCS-R; BNT; Token Test Verbal Memory impaired post-surgery. Naming decline 
post-surgery LTLLTL 32
Tests of executive function: WCST, FAS, TMT-B, Stroop, Hayling Sentence Completion Test, CANTAB: Intra Extra Dimensional Set Shifting, CANTAB: Stockings Problem; Tests of 
Verbal Memory—CVLT, RAVLT, WAIS Vocab, WMS-R: Logical Memory, WMS-R: Verbal Paired Associates, Token Test, VLMT: Verbaler Lern- und Merkfähigkeitstest; Tests of non-
verbal memory- ROCFT, WMS: Visual reproduction, WMS-R: Design Memory, WMS-R Visual Reproduction, WMS-III: Face Test, CANTAB: Spatial recognition memory, CANTAB: 
Pattern Recognition Memory, CANTAB: Paired Associates Learning; Attention span WAIS: Digit Span, Adult Memory and Information Processing Battery (AMIPB); sustained 
attention CPT; working memory SWMT, N-Back, WAIS: Letter Number Sequencing, WMS-III: Letter Number Sequencing, CANTAB: Spatial Working Memory.
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TaBLe 3 | Neuropsychological test findings summary table (for tests used more than once) in studies of bipolar disorder (BD) and temporal lobe epilepsy (TLE).
Measure BD                                TLe Pre- to 
post- 
surgical 
↑        ↓
Laterality 
effects
Use in studies, number of 
participants BD
BD < HC 
sig
Use in studies, number of 
participants TLe
sig
executive function
WCST 12 studies 11 2 studies 1 ↑1
BD n = 859, healthy controls (HC) 
n = 676
Right temporal lobe (RTL) n = 44, left 
temporal lobe (LTL) n = 49, HC n = 22
COWAT(FAS) 5 studies 2 2 studies 2 ↑1 Higher score 
LTL group 
pre- assoc. 
with greater 
impairment 
post-surg
RTL n = 33, LTL n = 38
BD n = 133, HC n = 130
TMT-B 9 studies 7
BD n = 513, HC = 339
Stroop 10 studies 7
BD n = 895, HC = 642
Hayling Sentence Completion Test 2 studies 2
BD n = 25, HC n = 73
CANTAB: Intra Extra Dimensional  
Set Shifting
2 studies 2
BD n = 140, HC n = 78
CANTAB: Stockings Problem 2 studies 2
BD n = 140, HC n = 78
verbal memory
CVLT 5 studies 3 7 studies 6 ↓6 Post-surg LTL 
decline 6
BD n = 233, HC n = 153 RTL n = 158, LTL n = 215, HC n = 10 RTL > LTL 1
(Continued)
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Measure BD                                TLe Pre- to 
post- 
surgical 
↑        ↓
Laterality 
effects
Use in studies, number of 
participants BD
BD < HC 
sig
Use in studies, number of 
participants TLe
sig
RAVLT 3 studies 2 5 studies 5 ↓5 Post-surg LTL 
decline 5BD n = 141, HC = 79 RTL n = 78, LTL n = 176, HC n = 28
Verbal comprehension: WAIS Vocab 4 studies 0
BD n = 187, HC n = 173
WMS-R: Logical Memory 6 studies 4 ↑3 ↓1 LTL < RTL 1
RTL n = 206, LTL n = 256, HC n = 28
WMS-R: Verbal Paired Associates 4 studies 4 ↑2 ↓1 LTL < RTL 1
RTL n = 119, LTL n = 151, HC n = 28
Token Test 2 studies 1 ↑1 Post-surg LTL 
improved 1RTL n = 34, LTL n = 47
VLMT: Verbaler Lern- und Merkfähigkeitstest 2 studies 2 ↓2
RTL n = 83, LTL n = 82
visuospatial memory
ROCFT 2 studies 0 3 studies 2 ↑1 LTL < RTL 1
BD n = 65, HC n = 47 RTL n = 25, LTL n = 62, HC n = 36
WMS: Visual reproduction 3 studies 0 2 studies 0
BD n = 105, HC n = 78 RTL n = 27, LTL n = 29
CANTAB: Spatial recognition memory 2 studies 2
BD n = 140, HC n = 78
CANTAB: Pattern Recognition Memory 2 studies 2
BD n = 140, HC n = 78
CANTAB: Paired Associates Learning 2 studies 2
BD n = 140, HC n = 78
WMS-R: Design Memory 4 studies 2 ↑1 ↓1 RTL decline 1
RTL n = 78, LTL n = 93, HC n = 28
WMS-R Visual Reproduction 5 studies 2 ↑1 ↓1 RTL decline 1
RTL n = 241, LTL n = 484, HC n = 28
WMS-III: Face Test 1 study 1 ↓1 RTL decline 1
RTL n = 16, LTL n = 10
Graduate Hospital Facial Memory 3 studies 3 ↑1 RTL < LTL 2
RTL n = 71, LTL n = 46, HC n = 10
Benton Visual Retention 2 studies 0
RTL n = 31, LTL n = 72
Diagnosticum für Cerebralschädigung 3 studies 2 ↓1
RTL n = 83, LTL n = 253
Spatial ability
WAIS: Block design 4 studies 0
BD n = 124, HC n = 109
attention span
WAIS: Digit Span 3 studies 2 4 studies 0
BD n = 103, HC n = 89 RTL n = 93, LTL n = 150, HC n = 15
TMT-A (also processing speed) 10 studies 8
BD n = 513, HC = 339
WAIS: Digit Symbol (also processing speed) 3 studies 3
BD n = 91, HC = 86
CANTAB: Rapid Visual Information 2 studies 2
BD n = 140, HC n = 78
(Continued)
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Measure BD                                TLe Pre- to 
post- 
surgical 
↑        ↓
Laterality 
effects
Use in studies, number of 
participants BD
BD < HC 
sig
Use in studies, number of 
participants TLe
sig
Adult Memory and Information Processing 
Battery (AMIPB)
2 studies 2 ↑1 ↓1
RTL n = 279, LTL n = 334
Sustained attention
CPT 4 studies 2
BD n = 84, HC n = 84
working memory
SWMT 2 studies 0
BD n = 30, HC n = 30
N-Back 2 studies 0
BD n = 45, HC n = 47
WAIS: Letter Number Sequencing 3 studies 3
BD n = 126, HC n = 126
WMS-III: Letter Number Sequencing 2 studies 3
BD n = 140, HC n = 78
CANTAB: Spatial Working Memory 2 studies 2
BD n = 140, HC n = 78
↑ refers to an increase, ↓ a decrease from pre- to post-surgery, sig refers to the number of studies with a significant result, laterality comments only significant main effects or 
interactions are discussed.
on statistically significant differences pre- to post-surgery and has 
not reported information in a form suitable for meta-analysis of 
pre-surgical cognitive functioning. Therefore, we have employed 
a systematic review methodology to examine and compare the 
profile of cognitive deficits in the two conditions. As indicated in 
the Section “Results,” the focus of inquiry of the neuropsychologi-
cal tests employed in the BD-I studies is predominantly on frontal 
lobe functions and in TLE on verbal and visuospatial memory.
There are significant differences in the experimental designs 
examining cognition in the two patient groups. In BD-I studies, 
cognition is tested broadly with a wide range of measures, with a 
HC comparison group and statistical control for medication use. 
This allows for observed deficits to be interpreted as trait markers 
of BD-I. This is further supported by familial studies that show 
similar patterns of impairments among family members and 
patients (89). By contrast, studies assessing cognitive performance 
in pre-surgical patients with epilepsy do so generally without HC. 
Only five studies included HC (n = 111), consequently the find-
ings have limited depth compared to those in the BD-I literature 
(n = 1,142). The pre-surgical neuropsychological workup consists 
mostly of tests of memory function, which is not surprising given 
that the surgery involves removing parts of or the whole temporal 
lobe.
In general, the studies on BD-I report the types of medications 
taken by patients at the time of testing (as shown in Table  1), 
which may have impacted the results. By contrast, in the epilepsy 
samples, it was typically not reported whether patients were receiv-
ing medication at the time of testing. A study that examined the 
effects of atypical antipsychotics on cognition in euthymic BD-I 
patients found that untreated patients showed better performance 
than those taking medication (93). Many patients with BD-I are 
treated with anticonvulsants that may worsen or enhance cogni-
tion (97). Of the total sample of 884 patients with BD-I included 
in the systematic review, 299 were taking lithium at the time of 
testing. A review of the effects of lithium on cognition found that 
impairments on tasks of psychomotor speed and verbal memory 
were present, whereas no effect was found on visuospatial ability 
or attention (97). Thus, cognitive performance may be impaired 
in various ways by different medications. A recent randomized 
crossover study examined the effects of methylene blue on cogni-
tion and mood-related symptoms in euthymic BD-I and BD-II. 
Neither low (15 mg) control doses nor high active doses (195 mg) 
had a significant effect on cognition (98). In rats, methylene blue 
prevents methylmalonate-induced seizures and oxidative damage 
in the striatum (99) providing interesting leads for future research 
into the overlaps between BD and epilepsy.
While this paper has provided an overview of the literature, 
it is subject to a number of limitations. One such factor is the 
differences of experimental designs in BD-I and TLE, which 
meant that a head-to-head meta-analytic comparison was not 
feasible. As discussed previously, the effect of medication was not 
uniformly controlled in BD-I and was either not reported or not 
systematically recorded in the epilepsy samples. In order to deter-
mine whether cognitive deficits are related to the illness and not 
undesirable side effect of medication, examination of otherwise 
stable drug-free patients would be of interest. The period of time 
between episodes (mania, depression, or seizures), time of test-
ing, hospitalizations, and the presence of psychotic features were 
not considered in this review. In BD-I patients, the presence of 
sub-clinical symptoms is common, even in those patients who are 
rated as euthymic at the time of testing and may have impacted 
performance overall (3).
TaBLe 3 | Continued
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